XT
LFCR icon

XTX Topco’s Lifecore Biomedical LFCR Stock Holding History

XTX Topco’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.6K Buy
+14,952
New +$103K ﹤0.01% 3287
2025
Q3 		– Sell
-20,089
Closed -$163K – 2938
2025
Q2 		$163K Sell
20,089
-510
-2% -$3.44K 0.01% 1767
2025
Q1 		$145K Buy
+20,599
New +$128K 0.01% 1773
2024
Q2 		– Sell
-12,610
Closed -$67K – 2189
2024
Q1 		$67K Buy
+12,610
New +$90.2K 0.01% 1423

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

XTX Topco's LFCR Position: Q1 2026 in Review

XTX Topco opened a new position in Lifecore Biomedical (LFCR) in Q1 2026: 14,952 shares worth $55.6K. The stake represents ﹤0.01% of the portfolio and ranks #3287 among its holdings. This is a return to the name: XTX Topco previously reported a position in LFCR as recently as Q2 2025.

XTX Topco first reported a position in LFCR in Q1 2024 and has held it in 4 quarters since. The position peaked at $163K in Q2 2025. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • XTX Topco held 14,952 shares of Lifecore Biomedical worth $55.6K as of Q1 2026.
  • Lifecore Biomedical was a new XTX Topco position in Q1 2026.
  • Lifecore Biomedical made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3287 holding.
  • XTX Topco first reported a position in Lifecore Biomedical in Q1 2024 and has held it in 4 quarters since.
  • XTX Topco's Lifecore Biomedical position peaked at $163K in Q2 2025.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.